It has been demonstrated that the vitreous bodies from patients with proliferative diabetic retinopathy are characterized by high levels of PGE2, and significantly correlated with VEGF secretion, suggesting the potential therapeutic role for nonsteroidal anti-inflammatory drugs in retinal complications of diabetes [74]. Here, VEGFA is linked to proliferative diabetic retinopathy.